During the past decade, Päijät-Hämeen keskussairaala conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Päijät-Hämeen keskussairaala" #1 collaborator was "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Päijät-Hämeen keskussairaala" are "Atrial Fibrillation" (1 trials), "Chronic Kidney Disease" (1 trials), "Diabetic Kidney Disease" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Päijät-Hämeen keskussairaala" in a lesser frequency.

Most popular intervention types in "Päijät-Hämeen keskussairaala" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Päijät-Hämeen keskussairaala" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Päijät-Hämeen keskussairaala". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Päijät-Hämeen keskussairaala, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Päijät-Hämeen keskussairaala, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".